Yin J - Search Results

1

Photodisruption of the Structurally Conserved Cys-Cys-Trp Triads Leads to Reduction-Resistant Scrambled Intrachain Disulfides in an IgG1 Monoclonal Antibody.

Wecksler AT, Yin J, Lee Tao P, Kabakoff B, Sreedhara A, Deperalta G. Wecksler AT, et al. Among authors: yin j. Mol Pharm. 2018 Apr 2;15(4):1598-1606. doi: 10.1021/acs.molpharmaceut.7b01128. Epub 2018 Mar 12. Mol Pharm. 2018. PMID: 29502420

2

Effect of ambient light on IgG1 monoclonal antibodies during drug product processing and development.

Sreedhara A, Yin J, Joyce M, Lau K, Wecksler AT, Deperalta G, Yi L, John Wang Y, Kabakoff B, Kishore RS. Sreedhara A, et al. Among authors: yin j. Eur J Pharm Biopharm. 2016 Mar;100:38-46. doi: 10.1016/j.ejpb.2015.12.003. Epub 2015 Dec 18. Eur J Pharm Biopharm. 2016. PMID: 26707077

3

Validation of a Spectral Method for Quantitative Measurement of Color in Protein Drug Solutions.

Yin J, Swartz TE, Zhang J, Patapoff TW, Chen B, Marhoul J, Shih N, Kabakoff B, Rahimi K. Yin J, et al. PDA J Pharm Sci Technol. 2016 Jul-Aug;70(4):382-91. doi: 10.5731/pdajpst.2016.006494. Epub 2016 Apr 18. PDA J Pharm Sci Technol. 2016. PMID: 27091890

4

A Spectral Method for Color Quantitation of a Protein Drug Solution.

Swartz TE, Yin J, Patapoff TW, Horst T, Skieresz SM, Leggett G, Morgan CJ, Rahimi K, Marhoul J, Kabakoff B. Swartz TE, et al. Among authors: yin j. PDA J Pharm Sci Technol. 2016 Jul-Aug;70(4):361-81. doi: 10.5731/pdajpst.2016.006486. Epub 2016 Apr 18. PDA J Pharm Sci Technol. 2016. PMID: 27091888

5

Compendial Methods: Suitability Verification, Challenges and Recommendations for Proteins.

Chung WL, Yin J, Messick S, Saggu M, Tschudi K, Woys A, Rahimi R, Azarias M, Kong C, Kabakoff B. Chung WL, et al. Among authors: yin j. PDA J Pharm Sci Technol. 2020 Sep-Oct;74(5):581-591. doi: 10.5731/pdajpst.2019.010652. Epub 2020 Apr 15. PDA J Pharm Sci Technol. 2020. PMID: 32295862

6

Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags.

Hui A, Yin J, Liu W, Zheng K. Hui A, et al. Among authors: yin j. Int J Pharm Compd. 2021 May-Jun;25(3):246-257. Int J Pharm Compd. 2021. PMID: 34125716

7

The Production, Quality Control, and Characterization of ZED8, a CD8-Specific ⁸⁹Zr-Labeled Immuno-PET Clinical Imaging Agent.

Gill H, Seipert R, Carroll VM, Gouasmat A, Yin J, Ogasawara A, de Jong I, Phan MM, Wang X, Yang J, Ilovich O, Marik J, Williams SP. Gill H, et al. Among authors: yin j. AAPS J. 2020 Jan 3;22(2):22. doi: 10.1208/s12248-019-0392-0. AAPS J. 2020. PMID: 31900688

8

New advances in the treatment of chondrosarcoma under the PD-1/PD-L1 pathway.

Yin J, Ren P. Yin J, et al. J Cancer Res Ther. 2024 Apr 1;20(2):522-530. doi: 10.4103/jcrt.jcrt_2269_23. Epub 2024 Apr 30. J Cancer Res Ther. 2024. PMID: 38687921 Review.

9

Editorial: One Health in clinical microbiology.

Xiu L, Kassegne K, Yin J. Xiu L, et al. Among authors: yin j. Front Cell Infect Microbiol. 2024 Apr 15;14:1404276. doi: 10.3389/fcimb.2024.1404276. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38686095 Free PMC article. No abstract available.

10

Efficacy of Flexible Ureteroscopy Lithotripsy and Percutaneous Nephrolithotomy in the Treatment of Patients with Kidney Stones and Their Impact on Inflammatory Response and Renal Function.

Wang J, Wang Y, Yin J, Xia L. Wang J, et al. Among authors: yin j. Ann Ital Chir. 2024;95(2):220-226. doi: 10.62713/aic.3175. Ann Ital Chir. 2024. PMID: 38684501

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,474 results

Search Page